Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Were Additional Treatments Affecting Pharmacokinetics Administered after Raltegravir Overdosing?: Authors' Reply.

Authors:
Tomohiro Hosoda Yuki Uehara Toshio Naito

Intern Med 2020 05 19;59(10):1343. Epub 2020 Feb 19.

General Medicine, Juntendo University, Japan.

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.4328-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303453PMC
May 2020

Publication Analysis

Top Keywords

additional treatments
4
treatments pharmacokinetics
4
pharmacokinetics administered
4
administered raltegravir
4
raltegravir overdosing?
4
overdosing? authors'
4
authors' reply
4
additional
1
pharmacokinetics
1
administered
1
raltegravir
1
overdosing?
1
authors'
1
reply
1

Keyword Occurance

Similar Publications

PharmacoGenetic targeting of a C. elegans essential neuron provides an in vivo screening for novel modulators of nematode ion channel function.

Authors:
Fernando Calahorro Mark Chapman Katarzyna Dudkiewicz Lindy Holden-Dye Vincent O'Connor

Pestic Biochem Physiol 2022 Aug 20;186:105152. Epub 2022 Jun 20.

School of Biological Sciences, University of Southampton, Life Sciences Building 85, Southampton SO17 1BJ, UK.

Chemical or drug treatments are successfully used to treat parasitic nematode infections that impact human, animal and plant health. Many of these exert their effects through modifying neural function underpinning behaviours essential for parasite viability. Selectivity against the parasite may be achieved through distinct pharmacological properties of the parasite nervous system, as exemplified by the success of the ivermectin which target a glutamate-gated chloride channel found only in invertebrates. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Self-Assembled Immunostimulatory Tetrahedral Framework Nucleic Acid Vehicles for Tumor Chemo-immunotherapy.

Authors:
Mengting Liu Liying Hao Dan Zhao Jiajie Li Yunfeng Lin

ACS Appl Mater Interfaces 2022 Aug 16. Epub 2022 Aug 16.

State Key Laboratory of Oral Disease, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.

Some chemotherapeutic agents, such as anthracyclines and oxaliplatin, can induce immunogenic cell death (ICD) with additional immune responses against cancer. However, ICD-based immunotherapy is limited by the nonspecific distribution of drugs and various side effects. Here, an immunostimulatory self-assembled tetrahedral framework nucleic acid (tFNA) vehicle was constructed to potentiate the chemo-immunotherapy, in which doxorubicin (DOX) acted as a chemotherapeutic agent and an ICD-inducer. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.

Authors:
Lynda Constable Paul Abrams David Cooper Mary Kilonzo Nikki Cotterill Chris Harding Marcus J Drake Megan N Pardoe Alison McDonald Rebecca Smith John Norrie Kirsty McCormack Craig Ramsay Alan Uren Tony Mundy Cathryn Glazener Graeme MacLennan

Health Technol Assess 2022 Aug;26(36):1-152

Health Services Research Unit, University of Aberdeen, Aberdeen, UK.

Background: Stress urinary incontinence is common in men after prostate surgery and can be difficult to improve. Implantation of an artificial urinary sphincter is the most common surgical procedure for persistent stress urinary incontinence, but it requires specialist surgical skills, and revisions may be necessary. In addition, the sphincter is relatively expensive and its operation requires adequate patient dexterity. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?

Authors:
Tommaso Ercoli Michele Tinazzi Christian Geroin Enrico Marcuzzo Roberto Erro Sofia Cuoco Roberto Ceravolo Sonia Mazzucchi Andrea Pilotto Alessandro Padovani Luigi Michele Romito Roberto Eleopra Mario Zappia Alessandra Nicoletti Carlo Dallocchio Carla Arbasino Francesco Bono Giorgio Spano Benedetta Demartini Orsola Gambini Nicola Modugno Enrica Olivola Laura Bonanni Alberto Albanese Gina Ferrazzano Alessandro Tessitore Leonardo Lopiano Giovanna Calandra-Buonaura Martina Petracca Francesca Morgante

J Neural Transm (Vienna) 2022 Aug 16. Epub 2022 Aug 16.

Neurosciences Research Centre, Molecular and Clinical Sciences Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.

The aim of this study is to assess changes in the body distribution and the semeiology of functional motor disorder (FMD) in patients who reported only one or more than one body site affected at FMD onset. Data were obtained from the Italian Registry of Functional Motor Disorders, which included patients with a diagnosis of clinically definite FMDs. The relationship between FMD features and spread to other body sites was estimated by multivariate Cox regression analysis. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies.

Authors:
Thomas B Casale Autumn Burnette Arnaud Bourdin Peter Howarth Beth Hahn Alexandra Stach-Klysh Sandhya Khurana

Ther Adv Respir Dis 2022 Jan-Dec;16:17534666221107313

Mary Parkes Center for Asthma, Division of Pulmonary and Critical Care Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Oral corticosteroids (OCS) have long been a mainstay of treatment for asthma exacerbations and chronic severe asthma. However, it is increasingly recognized that both long-term and short-term OCS use are directly associated with a wide range of serious adverse effects, and as such OCS-sparing treatment alternatives are now widely recommended for patients with severe asthma. While several international guidelines recommend these treatments, guidance on OCS tapering, and which patients are most likely to tolerate OCS reduction and/or discontinuation, is still lacking. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap